Laffer Tengler Investments increased its position in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) by 29.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,480 shares of the company’s stock after acquiring an additional 9,781 shares during […]
Laffer Tengler Investments increased its stake in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) by 29.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 43,480 shares of the company’s stock after purchasing an additional 9,781 shares during the period. AbbVie makes up 2.0% […]
Berkeley Capital Partners LLC lessened its stake in AbbVie Inc. (NYSE:ABBV – Get Rating) by 2.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,186 shares of the company’s stock after selling 196 shares during the quarter. Berkeley Capital Partners LLC’s holdings […]
Heritage Wealth Partners LLC purchased a new stake in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 1,704 shares of the company’s stock, valued at approximately $255,000. AbbVie makes up 0.2% of Heritage Wealth Partners LLC’s investment portfolio, […]
Capital Square LLC acquired a new stake in AbbVie Inc. (NYSE:ABBV – Get Rating) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,295 shares of the company’s stock, valued at approximately $209,000. A number of other hedge funds have also […]